(Q41688725)

English

IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951.

scientific article published on 8 June 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 October 2017

IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951. (English)

1 reference

Europe PubMed Central

7 October 2017

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

Nathalie Grardel

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

26

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

E Clappier

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

J Rapion

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

B De Moerloose

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

P Kastner

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

A Caye

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

J Vivent

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

V Costa

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

A Ferster

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

P Lutz

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

F Mazingue

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

F Millot

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

D Plantaz

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

G Plat

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

E Plouvier

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

M Poirée

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

N Sirvent

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

A Uyttebroeck

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

K Yakouben

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

S Girard

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

N Dastugue

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

S Suciu

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Y Benoit

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Y Bertrand

25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

European Organisation for Research and Treatment of Cancer, Children's Leukemia Group (EORTC-CLG)

27

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

8 June 2015

1 reference

Europe PubMed Central

7 October 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

29

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

2154-2161

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

https://scigraph.springernature.com/pub.10.1038/leu.2015.134

0 references

Acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.134

21 January 2018

Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.134

21 January 2018

A 50-year journey to cure childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.134

21 January 2018

Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.134

21 January 2018

The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.134

21 January 2018

Predicting relapse risk in childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.134

21 January 2018

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.134

21 January 2018

Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.134

21 January 2018

IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.134

21 January 2018

IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.134

21 January 2018

Impact of IKZF1 deletions on IKZF1 expression and outcome in Philadelphia chromosome negative childhood BCP-ALL. Reply to "incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philade

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.134

21 January 2018

Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.134

21 January 2018

Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.134

21 January 2018

Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.134

21 January 2018

Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.134

21 January 2018

IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.134

21 January 2018

A competitive PCR-based method using TCRD, TCRG and IGH rearrangements for rapid detection of patients with high levels of minimal residual disease in acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.134

21 January 2018

An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.134

21 January 2018

Breakpoint-specific multiplex polymerase chain reaction allows the detection of IKZF1 intragenic deletions and minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.134

21 January 2018

ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.134

21 January 2018

Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.134

21 January 2018

Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.134

21 January 2018

A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.134

21 January 2018

Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.134

21 January 2018

Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.134

21 January 2018

Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.134

21 January 2018

Beyond Philadelphia: 'Ph-like' B cell precursor acute lymphoblastic leukemias - diagnostic challenges and therapeutic promises

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.134

21 January 2018

Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.134

21 January 2018

RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.134

21 January 2018

Identifiers

10.1038/LEU.2015.134

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26050650%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41688725&oldid=1916981489"